Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) EBITDA (2019 - 2025)

Historic EBITDA for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • IM Cannabis' EBITDA rose 35281.91% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 15191.9%. This contributed to the annual value of -$5879.7 for FY2024, which is 9992.69% up from last year.
  • Per IM Cannabis' latest filing, its EBITDA stood at $2.8 million for Q3 2025, which was up 35281.91% from -$1.1 million recorded in Q2 2025.
  • IM Cannabis' 5-year EBITDA high stood at $15.5 million for Q2 2022, and its period low was -$97.7 million during Q3 2022.
  • Over the past 5 years, IM Cannabis' median EBITDA value was $432.79 (recorded in 2025), while the average stood at -$5.7 million.
  • Examining YoY changes over the last 5 years, IM Cannabis' EBITDA showed a top increase of 48845.73% in 2022 and a maximum decrease of 33777593.43% in 2022.
  • Quarter analysis of 5 years shows IM Cannabis' EBITDA stood at $7395.5 in 2021, then plummeted by 337775.93% to -$25.0 million in 2022, then skyrocketed by 48.46% to -$12.9 million in 2023, then soared by 152.42% to $6.7 million in 2024, then tumbled by 58.38% to $2.8 million in 2025.
  • Its EBITDA stands at $2.8 million for Q3 2025, versus -$1.1 million for Q2 2025 and $432.79 for Q1 2025.